Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
Completed · Phase 2
Conditions studied: Chronic HBV Infection
In brief
The primary objectives of this study are to evaluate the safety and efficacy of GS-4774 in adults with chronic hepatitis B (CHB) viral infection who have been virally suppressed with an oral antiviral (OAV) medication.
Key facts
- Study ID
- NCT01943799
- Run by
- Gilead Sciences
- People needed
- 178
- Starts
- 2013-09-13
- Expected to finish
- 2015-03-03
- Last updated by the study team
- 2019-11-01
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Dumont-UCLA Liver Transplant Center — Los Angeles, California, United States
- Huntington Medical Research Institutes — Pasadena, California, United States
- Kaiser Permanente — Sacramento, California, United States
- Kaiser Permanente — San Diego, California, United States
- Kaiser Permanente — San Francisco, California, United States
- Silicon Valley Research Institute — San Jose, California, United States
- University of Miami — Miami, Florida, United States
- Northwestern Memorial Hospital — Chicago, Illinois, United States
- Digestive Disease Associates, PA — Baltimore, Maryland, United States
- Tufts Medical Center — Boston, Massachusetts, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Henry Ford Hospital and Health System — Detroit, Michigan, United States
- St.Louis University — St Louis, Missouri, United States
- Medical Pro-care — Flushing, New York, United States
- North Shore LIJ Health System — Manhasset, New York, United States
- Bon Secours St. Mary's Hospital of Richmond — Newport News, Virginia, United States
- Auckland Clinical Studies — Grafton, New Zealand
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.